Skip to main content

Hyoscyamine

NDC 51525-0115 · Mylan Pharmaceuticals Inc.

Generic namehyoscyamine sulfate
Dosage formTABLET, EXTENDED RELEASE
RouteORAL
Active ingredient(s)HYOSCYAMINE SULFATE
Strength.375 mg/1
Marketing categoryUNAPPROVED DRUG OTHER

Packages

51525-0115-1 — 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (51525-0115-1)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

39328-050 — Hyoscyamine Sulfate, 39328-051 — Hyoscyamine Sulfate, 39328-052 — Hyoscyamine Sulfate, 42192-338 — hyoscyamine sulfate, 42192-339 — hyoscyamine sulfate, 42192-340 — hyoscyamine sulfate, 42708-183 — hyoscyamine sulfate, 50742-665 — Phenobarbital, Hyoscyamine Sulfate, Atropine Sulfate, Scopolamine Hydrobromide, 50742-666 — Phenobarbital, Hyoscyamine Sulfate, Atropine Sulfate, Scopolamine Hydrobromide, 50742-667 — Phenobarbital, Hyoscyamine Sulfate, Atropine Sulfate and Scopolamine Hydrobromide, 51655-764 — Hyoscyamine Sulfate, 51655-845 — hyoscyamine sulfate, 54288-111 — HYOSCYAMINE SULFATE, 54838-506 — Hyoscyamine Sulfate, 54838-511 — Hyoscyamine Sulfate, 58657-456 — Methenamine, Sodium Phosphate, Monobasic, Anhydrous, Phenyl Salicylate, Methylene Blue and Hyoscyamine Sulfate, 59088-150 — Hyoscyamine Sulfate 0.125 mg, 59212-422 — phenobarbital, hyoscyamine sulfate, atropine sulfate, scopolamine hydrobromide, 59212-423 — phenobarbital, hyoscyamine sulfate, atropine sulfate, scopolamine hydrobromide, 59212-425 — PHENOBARBITAL, HYOSCYAMINE SULFATE, ATROPINE SULFATE, SCOPOLAMINE HYDROBROMIDE, +51 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels